Cheng-ying Chu
Taipei, TNQ 11031, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Chronic exposure to chlorate at regulatory safety limits induces p21/p16-mediated neuronal senescence and Parkinsonian-like decline.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: March 27, 2026
SIAH2-WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer.
Journal: International journal of molecular sciences
Published: December 08, 2025
Melatonin suppresses glycolysis and coordinately disrupts DNA repair via targeting the YAP1-NAMPT signaling in breast cancer.
Journal: Chemico-biological interactions
Published: November 01, 2025
Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.
Journal: Biomarker research
Published: August 08, 2025
Metastatic breast cancer cells are vulnerable to fatty acid oxidation inhibition through DDX3-DRP1-mediated mitochondrial plasticity.
Journal: Redox biology
Published: July 09, 2025
Photobiomodulation as a therapeutic approach for attention-deficit/hyperactivity disorder in model rats.
Journal: Lasers in medical science
Published: June 27, 2025
YAP Expression Confers Therapeutic Vulnerability to Cuproptosis in Breast Cancer Cells by Regulating Copper Homeostasis.
Journal: Advanced healthcare materials
Published: June 02, 2025
Abemaciclib impairs glioblastoma sphere formation by targeting the GSK3β-mediated transcriptional regulation of CD44 and TCF7L2.
Journal: Cancer gene therapy
Published: April 20, 2025
FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer.
Journal: Cell death & disease
Published: January 14, 2025
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment.
Journal: Journal of biomedical science
Published: October 16, 2024
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer.
Journal: Cell death & disease
Published: July 27, 2024
Melatonin increases Olaparib sensitivity and suppresses cancer-associated fibroblast infiltration via suppressing the LAMB3-CXCL2 axis in TNBC.
Journal: Pharmacological research
Published: July 26, 2024
Last Updated: 09/26/2026